For citations:
Kuzmin O.B., Zhezha V.V., Belaynin V.V., Landar L.N. DRUG THERAPY FOR PATIENTS WITH CHRONIC KIDNEY DISEASE: IS THERE A PLACE FOR DOUBLE NEPRILYSIN AND AT1-ANGIOTENSIN RECEPTOR INHIBITOR LCZ696 (SACUBITRIL/VALSARTAN)? Nephrology (Saint-Petersburg). 2018;22(2):59-67. (In Russ.) https://doi.org/10.24884/1561-6274-2018-22-2-59-67